AS ONE Corporation

Equities

7476

JP3131300000

Medical Equipment, Supplies & Distribution

Market Closed - Japan Exchange Other stock markets 02:00:00 2024-04-19 am EDT			5-day change	1st Jan Change
2,506 ^JPY	-2.74%		-4.53%	-10.50%

Mar. 13	As One's Net Sales Up More Than 7% in February	MT
Mar. 13	Tranche Update on AS ONE Corporation's Equity Buyback Plan announced on March 12, 2024.	CI

AS ONE : February 2022 Operating Results (Flash Report)

March 09, 2022 at 01:31 am EST

March 9th 2022

AS ONE CORPORATION

President：Takaji Iuchi

Security Code:7476

Contact：Keisuke Nishikawa Director

TEL: +81-6-6447-1210

February 2022 Operating Results (Flash Report)

１．Net Sales trends

Millions of yen

Apr.

May

Jun.

Jul.

Aug.

Sep.

FY03/2022

6,493

5,860

6,753

6,380

6,168

6,691

FY03/2021

5,808

4,700

5,618

5,758

5,233

6,304

FY03/2022

+11.8%

+24.7%

+20.2%

+10.8%

+17.9%

+6.1%

% YoY

Oct.

Nov.

Dec.

Jan.

Feb.

Mar.

FY03/2022

6,581

6,706

7,006

7,445

7,727

FY03/2021

6,794

6,432

7,306

7,191

7,615

8,971

FY03/2022

（3.1）%

+4.3%

（4.1）%

+3.5%

+1.5%

% YoY

２．Business day

Apr.

May

Jun.

Jul.

Aug.

Sep.

Oct.

Nov.

Dec.

Jan.

Feb.

Mar.

FY03/2022

YoY

± 0

（ 1）

＋ 1

± 0

（ 1）

＋ 1

± 0

Sales per day

+11.8%

+24.7%

+20.2%

+16.3%

+11.7%

+6.1%

+1.5%

（1.0）%

（4.1）%

+3.5%

+1.5%

％ YoY*

Note: AS ONE places particular emphasis on net sales per day, as sales of consumables used in research, industrial and medical fields tend to fluctuate according to variations in the total number of operating days.

３．Reference

Results for FYE 03/2022 are subject to residual YoY impact stemming from special environmental circumstances observed in FYE 03/2021, including special COVID-19-related demand. Accordingly, we suggest that you also refer to comparisons between results in FYE 03/2022 and FYE 03/2020.

	Apr.	May	Jun.	Jul.	Aug.	Sep.
	+31.4%	+19.4%	+36.5%	+14.6%	+32.9%	+17.0%
Vs. 3/2020	Oct.	Nov.	Dec.	Jan.	Feb.	Mar.
	+27.5%	+30.4%	+28.3%	+29.3%	+19.7%

About this material

The figures in these materials are non-consolidated figures that contain some provisional numbers from early reporting. They are provided to show trends for the convenience of investors. Temporarily uncategorized net sales, and adjustments for intra-Group transactions and deductions in consolidated financials are not accounted for. For purposes of reference, in fiscal year ended March 2021, the total annual net sales under this method were 77,729 million yen, annual net sales on a non-consolidated basis were 78,839 million yen, and consolidated net sales were 81,606 million yen.

The disclosure of this report in Jun., Sep., Dec. and Mar. will be made at the same time as the disclosure of the Summary of Financial Results.

1/4

Millions of yen・％

Scientific sector

5,000

+80.0%

FY03/2021

FY03/2022

FY03/2021

FY03/2022

% YoY

4,500

+70.0%

4,000

+60.0%

3,500

+50.0%

+41.8%

3,000

+40.0%

2,500

+30.0%

+26.1%

+20.2%

+19.7%

2,000

+20.0%

+16.9%

+16.2%

+14.9%

+15.0%	+12.8%	+12.5%		+15.0%
	+13.5%	+10.1%	+14.1%

1,500		+7.3%	+8.7%

		+3.3%		+5.1%

+11.2%	+11.0%
+9.4%	+10.0%

1,000

+0.0%

500

（10.0）%

（16.0）%

（20.0）%

Apr.

May

Jun.

Jul.

Aug.

Sep.

Oct.

Nov.

Dec.

Jan.

Feb.

Mar.

Apr.

May

Jun.

Jul.

Aug.

Sep.

Oct.

Nov.

Dec.

Jan.

Feb.

Mar.

FY03/2020

2,594

2,683

2,785

3,081

2,548

3,187

2,889

2,918

3,178

3,391

3,771

4,375

FY03/2021

2,982

2,254

3,142

3,184

2,892

3,508

3,642

3,410

3,821

3,870

4,193

4,857

FY03/2022

3,465

3,197

3,762

3,584

3,324

3,764

3,827

3,923

4,152

4,498

4,587

FY03/2021

+15.0%

（16.0）%

+12.8%

+3.3%

+13.5%

+10.1%

+26.1%

+16.9%

+20.2%

+14.1%

+11.2%

+11.0%

% YoY

FY03/2022

+16.2%

+41.8%

+19.7%

+12.5%

+14.9%

+7.3%

+5.1%

+15.0%

+8.7%

+16.2%

+9.4%

% YoY

2/4

					Millions of yen・％
	Industrial sector
4,000						+60.0%

		FY03/2021	FY03/2022	FY03/2021	FY03/2022

				% YoY	% YoY
3,500						+50.0%

3,000		+40.0%

2,500

+28.4%

+30.0%

+21.7%

+19.8%

2,000

+19.8%

+18.7%

+20.0%

+8.9%

+10.5%

+9.1%

1,500

+10.0%

+7.5%

+6.0%

+4.0%

+4.2%

+4.1%

+1.0%	+1.1%	+3.7%
1,000	（0.9）%

+2.5%

+1.3%

+0.0%

（8.0）%

500

（12.1）%

（13.9）%

（10.0）%

（20.0）%

Apr.

May

Jun.

Jul.

Aug.

Sep.

Oct.

Nov.

Dec.

Jan.

Feb.

Mar.

Apr.

May

Jun.

Jul.

Aug.

Sep.

Oct.

Nov.

Dec.

Jan.

Feb.

Mar.

FY03/2020

1,187

1,179

1,177

1,360

1,104

1,289

1,244

1,248

1,204

1,284

1,374

1,564

FY03/2021

1,277

1,037

1,189

1,171

1,015

1,278

1,355

1,301

1,429

1,332

1,409

1,706

FY03/2022

1,354

1,242

1,446

1,403

1,304

1,355

1,410

1,438

1,444

1,387

1,427

FY03/2021

+7.5%

（12.1）%

+1.0%

（13.9）%

（8.0）%

（0.9）%

+8.9%

+4.2%

+18.7%

+3.7%

+2.5%

+9.1%

% YoY

FY03/2022

+6.0%

+19.8%

+21.7%

+19.8%

+28.4%

+6.0%

+4.0%

+10.5%

+1.1%

+4.1%

+1.3%

% YoY

3/4

								Millions of yen・％
		Hospital and Nursing
4,000	Care Sector					+96.0%
FY03/2021	FY03/2022		FY03/2021	FY03/2022	+90.9%



					% YoY	% YoY	+83.8%
3,500								+80.0%
				+75.1%	+76.4%

3,000+64.0%

+53.4%

2,500

+48.0%

+33.6%

+34.9%

+34.1%

+33.2%

2,000

+30.4%

+32.0%

+24.5%

+22.3%

+20.0%

1,500

+16.2%

+16.0%

+8.1%

+3.6%

+0.8%

1,000

（0.7）%

+0.0%

（14.9）%

500

（16.0）%

（21.8）%

（21.5）%

（25.2）%

（31.4）%

（32.0）%

Apr.

May

Jun.

Jul.

Aug.

Sep.

Oct.

Nov.

Dec.

Jan.

Feb.

Mar.

Apr.

May

Jun.

Jul.

Aug.

Sep.

Oct.

Nov.

Dec.

Jan.

Feb.

Mar.

FY03/2020

1,159

1,045

987

1,127

989

1,241

1,026

976

1,077

1,082

1,313

1,807

FY03/2021

1,549

1,410

1,287

1,403

1,326

1,518

1,797

1,721

2,057

1,989

2,013

2,407

FY03/2022

1,674

1,421

1,544

1,393

1,540

1,572

1,344

1,346

1,410

1,560

1,713

FY03/2021

+33.6%

+34.9%

+30.4%

+24.5%

+34.1%

+22.3%

+75.1%

+76.4%

+90.9%

+83.8%

+53.4%

+33.2%

% YoY

FY03/2022

+8.1%

+0.8%

+20.0%

（0.7）%

+16.2%

+3.6%

（25.2）%

（21.8）%

（31.4）%

（21.5）%

（14.9）%

% YoY

Rapid growth in October of FYE 03/2021 was primarily due to

heavy impact from demand created associated with stringentCovid-19has begun to spread in Japan medical care conditions and recovery from a prior decline in

performance associated with a consumption tax increase implemented in October 2019.

4/4

Attachments

Original Link
Original Document
Permalink

Disclaimer

As One Corporation published this content on 09 March 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 09 March 2022 06:30:14 UTC.

Latest news about AS ONE Corporation

As One's Net Sales Up More Than 7% in February	Mar. 13	MT
Tranche Update on AS ONE Corporation's Equity Buyback Plan announced on March 12, 2024.	Mar. 12	CI
AS ONE Corporation's Equity Buyback announced on March 12, 2024, has closed with 400,000 shares, representing 1.1% for ¥2,076.4 million.	Mar. 12	CI
AS ONE Corporation Reports Sales Results for the Month of February 2024	Mar. 12	CI
AS ONE Corporation announces an Equity Buyback for 440,000 shares, representing 1.22% for ¥2,284.04 million.	Mar. 12	CI
AS ONE Corporation authorizes a Buyback Plan.	Mar. 11	CI
AS ONE Corporation Reports Sales Results for the Month of January 2024	Feb. 08	CI
AS ONE Corporation Provides Consolidated Earnings Guidance for the Full Year Ending March 31, 2024	Feb. 01	CI
AS ONE Corporation Provides Year End Dividend Guidance for the Year Ending March 31, 2024	Feb. 01	CI
AS ONE Corporation Reports Sales Results for the Month of December 2023	Jan. 31	CI
As One's Net Sales Up 6% in November	Dec. 13	MT
AS ONE Corporation Reports Sales Results for the Month of November 2023	Dec. 12	CI
AS ONE Corporation Reports Sales Results for the Month of October 2023	Nov. 09	CI
AS ONE Corporation Revises Year-End Dividend Guidance for the Fiscal Year Ending March 31, 2024	Nov. 09	CI
AS ONE Corporation Declarers Dividend for the End of Second Quarter of Full Year Ending March 31, 2024, Payable on December 4, 2023	Nov. 02	CI
AS ONE Corporation Provides Year-End Dividend Guidance for the Full Year Ending March 31, 2024	Nov. 02	CI
As One Corporation Provides Consolidated Earnings Guidance for the Full Year Ending March 31, 2024	Nov. 02	CI
AS ONE Corporation Reports Sales Results for the Month of September 2023	23-10-31	CI
Co-LABO MAKER Co., Ltd. announced that it has received ¥190 million in funding from Deepcore Inc., QB Capital, LLC, Kips Co., Ltd., Governance Partners Co., Ltd. and other investors	23-10-10	CI
Co-LABO MAKER Co., Ltd. announced that it expects to receive funding from a group of investors	23-09-28	CI
As One Corporation Announces Sales Results for the Month of June 2023	23-09-12	CI
AS ONE Corporation provides dividend guidance for the end of second quarter of full year ending March 31, 2024	23-08-01	CI
AS ONE Corporation Provides Year-End Dividend Guidance for the Full Year Ending March 31, 2024	23-08-01	CI
AS ONE Corporation Provides Consolidated Earnings Guidance for the Six Months Ending September 30, 2023 and Full Year Ending March 31, 2024	23-08-01	CI
AS ONE Corporation Announces Sales Results for the Month of June 2023	23-07-31	CI

Chart AS ONE Corporation

Duration

Period

More charts

Company Profile

As One Corp is a Japan-based company principally engaged in the sale of scientific equipment and apparatus for various laboratories, research institutes, production facilities and medical facilities. The research and industrial equipment business is engaged in the wholesale of equipment and apparatus, which is used by researchers and technicians, to scientific equipment dealers. This business is also engaged in the provision of product catalogs to dealers, as well as the import and sale of physics and chemistry equipment. The hospital and nursing care business is engaged in the wholesale of equipment and apparatus, which is used by nursing care-related persons, to medical and nursing care institutions. The other business provides purchasing business proxy service using a web system, and to receive the system usage fee by the final user who participates in the system.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-05-13 - Q4 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for AS ONE Corporation

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

2,576 JPY

Average target price

3,500 JPY

Spread / Average Target

+35.84%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Equipment Wholesale

	1st Jan change	Capi.
AS ONE CORPORATION	-10.50%	1.19B
HENRY SCHEIN, INC.	-7.61%	8.99B
OWENS & MINOR, INC.	+24.86%	1.84B
SHIP HEALTHCARE HOLDINGS, INC.	-10.61%	1.31B
GKHT MEDICAL TECHNOLOGY CO., LTD.	-20.58%	835M
TOKAI CORP.	-0.77%	478M
EXCELSIOR MEDICAL CO., LTD.	+7.01%	453M
COWEALTH MEDICAL CHINA CO.,LTD.	-27.08%	323M
GAUSH MEDITECH LTD	-55.03%	324M
WIN-PARTNERS CO., LTD.	-2.84%	217M

Medical Equipment Wholesale